111
|
|
|
Immunoglobulin mu DNA binding protein 2 |
CATF1, CMT2S, HCSA, HMN6, HMNR1, SMARD1, SMUBP2, ZFAND7 |
|
112
|
|
|
IgA inducing protein |
C5orf53 |
|
113
|
|
|
Immunoglobulin lambda locus |
IGL@, IGLC6 |
|
114
|
|
|
Immunoglobulin lambda like polypeptide 1 |
14.1, AGM2, CD179b, IGL1, IGL5, IGLJ14.1, IGLL, IGO, IGVPB, VPREB2 |
|
115
|
|
|
IgLON family member 5 |
- |
|
116
|
|
|
Immunoglobulin superfamily member 1 |
CHTE, IGCD1, IGDC1, INHBP, PGSF2, p120 |
|
117
|
|
|
Immunoglobulin superfamily member 10 |
CMF608 |
|
118
|
|
|
Immunoglobulin superfamily member 11 |
BT-IgSF, BTIGSF, CT119, CXADRL1, Igsf13, VSIG3 |
Alzheimer disease, Atrial fibrillation, Attention deficit hyperactivity disorder, Bipolar disorder, Cannabis abuse, Colorectal cancer, Dementia, Essential tremor, Insomnia, Major depressive disorder, Metabolic syndrome, Neurotic disorder, Obesity, Parkinson disease, Psychiatric disorders, Willis-ekbom disease, Schizophrenia, Scoliosis, Substance abuse, Diabetes mellitus type 2View all (5 more) |
119
|
|
|
Immunoglobin superfamily member 21 |
- |
Attention deficit hyperactivity disorder, Atypical femoral fracture, Breast cancer, Central nervous system cancer, Diabetic retinopathy, Glioblastoma, Glioma, Lung cancer, Neurotic disorder, Pancreatic cancer, Pelvic organ prolapse, Squamous cell carcinoma, Substance abuse, Diabetes mellitus type 2, Urinary bladder neoplasms |
120
|
|
|
Immunoglobulin superfamily member 22 |
IGFN2 |
|